Android app Apple app link

Avidity Biosciences, Inc. (RNA) Latest News

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$71.61

$0.26 (0.36%)
Last update: 12:05 PM EST
Day's range
$71.34
Day's range
$71.64

Latest News of RNA

3 Cold Dishes review - Burna Boy produces deftly directed revenge tales with echoes of Kill Bill

3 Cold Dishes review - Burna Boy produces deftly directed revenge tales with echoes of Kill Bill

By The Guardian | 1 month ago
Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger

Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger

By Yahoo! Finance | 1 month ago
Lawyer-Turned-Comedian Zarna Garg Reflects on Starting Stand-Up at 44, Says Being 'Inauthentic Is a Lot of Work' (Exclusive)

Lawyer-Turned-Comedian Zarna Garg Reflects on Starting Stand-Up at 44, Says Being 'Inauthentic Is a Lot of Work' (Exclusive)

By PEOPLE.com | 1 month ago
Avidity Biosciences (RNA) Soars to All-Time High on Looming $12-Billion Merger with Novartis

Avidity Biosciences (RNA) Soars to All-Time High on Looming $12-Billion Merger with Novartis

By Yahoo! Finance | 1 month ago
Novartis to acquire Avidity in $12B bet on RNA drugs for neuromuscular disease

Novartis to acquire Avidity in $12B bet on RNA drugs for neuromuscular disease

By Yahoo! Finance | 1 month ago
Klarna Takes Aim At Premium Credit Cards With Its New Membership Program

Klarna Takes Aim At Premium Credit Cards With Its New Membership Program

By Yahoo! Finance | 1 month ago
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

By Yahoo! Finance | 1 month ago
Byrna Technologies Inc. (BYRN): A Bull Case Theory

Byrna Technologies Inc. (BYRN): A Bull Case Theory

By Yahoo! Finance | 1 month ago
How Investors May Respond To Moderna (MRNA) Halting Development of mRNA-1647 CMV Vaccine

How Investors May Respond To Moderna (MRNA) Halting Development of mRNA-1647 CMV Vaccine

By Yahoo! Finance | 1 month ago
Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA?

Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA?

By Yahoo! Finance | 1 month ago
The next cancer-fighting mRNA vaccine may already be here

The next cancer-fighting mRNA vaccine may already be here

By NBC News | 1 month ago
Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout

Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout

By Yahoo! Finance | 1 month ago
Why Moderna Might Be a One-Hit Wonder

Why Moderna Might Be a One-Hit Wonder

By Yahoo! Finance | 1 month ago
Husqvarna AB (publ) (HUSQ-B.ST) Stock Price, News, Quote & History

Husqvarna AB (publ) (HUSQ-B.ST) Stock Price, News, Quote & History

By Yahoo! Finance | 1 month ago
What Makes Avidity Biosciences (RNA) an Investment Choice?

What Makes Avidity Biosciences (RNA) an Investment Choice?

By Yahoo! Finance | 1 month ago

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.